ESTABLISHEDSCIENCEscience-backed 98%

Cancer-Induced Muscle Circadian Disruption

Quality 79/10098 signals7 source typessince 2025-05-09

What is this

This trend examines the disruption of muscle circadian rhythms induced by cancer, linking biological clock disturbances to cachexia and muscle degradation. It focuses on uncovering biomarkers and potential drug targets to mitigate muscle wasting in cancer patients.

Why it matters

With an aging global population and rising incidences of cancer, understanding and intervening in cancer-induced cachexia has become a critical medical need. The integration of multi-omics studies and clinical trials fuels the pursuit of novel therapies to improve quality of life.

Investment angle

Investors might target biotech startups or pharmaceutical companies that are developing drugs to counteract cancer cachexia. Additionally, one could consider ETFs or venture funds focusing on precision medicine and aging-related interventions.

Sovenyr read

Attractive for risk-tolerant investors interested in biotech innovation, though high hurdles remain; investability: 7/10.

History

Flagged 2025-05-09 · Status ESTABLISHED (since 2026-03-11) · last active 2026-07-28
2026-03-07signals (cumulative): 5 → 982026-07-28
Y = cumulative signals, X = time. A steep climb means the cluster is actively growing; a flat or abruptly-ending line means momentum is gone.
datesignalsnewsubstance
2026-03-075100%
2026-03-1874+69100%
2026-03-2976+299%
2026-04-0976+099%
2026-04-2079+399%
2026-05-0188+999%
2026-05-1488+099%
2026-05-2490+298%
2026-06-0491+198%
2026-06-1593+298%
2026-06-2693+098%
2026-07-0695+298%
2026-07-1798+398%
2026-07-2898+098%

Evidence

The 98 collected signals behind this trend — the 20 most recent, each linking to its primary source.
See the live dataTrack record